Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-061002

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Molineaux
Officer — SR. VP, DEVELOPMENT
Period of report
Jul 13, 2015
Accepted (ET)
Jul 15, 2015 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 13, 2015M14,087$0.96A16,587D
Common StockF1Jul 13, 2015M10,288$2.64A26,875D
Common StockF2holding———117,962IBy Trust
Common Stockholding———78,787IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$0.96Jul 13, 2015M14,087D—May 22, 2023Common Stock14,08724,924D
Stock Option (Right to Buy)F4$2.64Jul 13, 2015M10,288D—Dec 16, 2023Common Stock10,28823,745D
Stock Option (Right to Buy)F5$0.48Jul 13, 2015M15,282D—Dec 13, 2021Common Stock15,2824,367I
Stock Option (Right to Buy)F6$0.48Jul 13, 2015M14,330D—Jun 12, 2022Common Stock14,3309,922I
Stock Option (Right to Buy)F3$0.96Jul 13, 2015M16,396D—May 22, 2023Common Stock16,39629,009I
Stock Option (Right to Buy)F4$2.64Jul 13, 2015M30,279D—Dec 16, 2023Common Stock30,27985,434I

Explanation of responses